Val-boro-pro; PT-100; UNII-KZ1O2SH88Z; Val-boroPro; KZ1O2SH88Z; CHEMBL67279; Pyrrolidine derivative; PT100; [(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid; ((R)-1-(L-Valyl)pyrrolidin-2-yl)boronic acid; Talabostat(PT100); Talabostat [USAN:INN]; PT 100; ValboroPro; ((2R)-1-((2S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic acid; Boronic acid, ((2R)-1-((2S)-2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-; Boronic acid, [(2R)-1-[(2S)-2-amino-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-; Valinyl-L-Boroproline; Ketopyrrolidine derivative; Talabostat (USAN/INN); SCHEMBL393024; C9H19BN2O3; GTPL9892; CTK0H0433; EX-A3155; ((R)-1-((S)-2-Amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic acid; 8274AH; BDBM50050513; ZINC169746694; compound 1 [PMID: 18783201]; CS-6996; DB06182; HY-13233; A18222; D05989; (2R)-1-(L-Valyl)-2alpha-(dihydroxyboryl)pyrrolidine; Q27282515; (R)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-ylboronic acid; (S)-2-Amino-3-methyl-2-boronic acid-1-pyrrolidin-1-yl-butan-1-one; [(2R)-1-[(2S)-2-Amino-3-methyl-1-oxobutyl]-2-pyrrolidinyl]boronic acid; (S)-2-Amino-1-((R)-2-dihydroxyboron-pyrrolidin-1-yl)-3-methyl-butan-1-one; Boronic acid, (1-(2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-, (R-(R*,S*))-